Australia's most trusted
source of pharma news
Wednesday, 08 October 2025
Posted 8 October 2025 PM
Boehringer Ingelheim is the number one Big Pharma for corporate reputation, according to diabetes patient groups.
Patient groups “working with” Big Pharma companies named Boehringer first, AstraZeneca second and Roche third in PatientView’s 2024 Corporate Reputation of Pharma survey of 79 diabetes patient groups worldwide.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.